Farallon Capital Management, L.L.C. / SRPT
Farallon Capital Management, L.L.C.’s Sarepta Therapeutics Inc Position
Does Farallon Capital Management, L.L.C. own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 2.34M shares worth $149M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$149M
Q1 2025
Shares
2.34M
% of Portfolio
+0.80%
Quarters Held
23
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 2.34M | $149M | +0.80% |
| Q4 2024 | 2.87M | $348M | +1.77% |
| Q3 2024 | 2.58M | $322M | +1.57% |
| Q2 2024 | 2.29M | $363M | +1.71% |
| Q1 2024 | 2.45M | $318M | +1.44% |
| Q4 2023 | 1.21M | $117M | +0.51% |
| Q3 2023 | 1.38M | $167M | +0.72% |
| Q2 2023 | 1.21M | $138M | +0.77% |
| Q1 2023 | 913.3K | $126M | +0.62% |
| Q4 2022 | 928.9K | $120M | +0.79% |
| Q3 2022 | 755.0K | $83M | +0.46% |
| Q2 2022 | 1.19M | $89M | +0.50% |
| Q1 2022 | 992.0K | $77M | +0.34% |
| Q4 2021 | 839.0K | $76M | +0.39% |
| Q3 2021 | 162.0K | $15M | +0.07% |
| Q1 2021 | 300.0K | $22M | +0.12% |
| Q4 2020 | 600.0K | $102M | +0.65% |
| Q3 2020 | 600.0K | $84M | +0.59% |
| Q2 2020 | 525.0K | $84M | +0.68% |
| Q1 2020 | 350.0K | $34M | +0.21% |
| Q2 2019 | 500.0K | $76M | +0.63% |
| Q1 2019 | 650.0K | $77M | +0.62% |
| Q4 2018 | 640.0K | $70M | +0.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of SRPT.